Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction

[1]  K. Nakashima,et al.  [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[2]  Jianjun Zhang,et al.  Association of deoxyribonuclease I genetic polymorphisms with myocardial infarction in Han Chinese , 2009, Molecular Biology Reports.

[3]  Scott M. Williams,et al.  Male–female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population , 2008, Human Genetics.

[4]  R. Macko,et al.  Microvascular tissue plasminogen activator is reduced in diabetic neuropathy , 2007, Neurology.

[5]  S. Yusuf,et al.  Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. , 2007, JAMA.

[6]  D. Newby,et al.  Tissue plasminogen activator genetic polymorphisms do not influence tissue plasminogen activator release in patients with coronary heart disease , 2006, Journal of thrombosis and haemostasis : JTH.

[7]  M. Castellano.  Geographic ancestry, angiotensinogen gene polymorphism, and cardiovascular risk. , 2006, Hypertension.

[8]  N. Chaturvedi,et al.  Risk factors for non-fatal myocardial infarction in young South Asian adults , 2004, Heart.

[9]  B. Peterlin,et al.  4G4G Genotype of PAI-1 Gene Promoter Polymorphism Is Not Associated with Myocardial Infarction in Caucasians with Type-2 Diabetes , 2003, Cardiology.

[10]  M. Margaglione,et al.  The plasminogen activator inhibitor‐1 −675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study , 2003, Journal of thrombosis and haemostasis : JTH.

[11]  A. Sharrett,et al.  Lack of association of the plasminogen activator inhibitor‐1 4G/5G promoter polymorphism with cardiovascular disease in the elderly , 2003, Journal of thrombosis and haemostasis : JTH.

[12]  H. Izawa,et al.  Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. , 2002, The New England journal of medicine.

[13]  K. Lewandrowski,et al.  Cardiac markers for myocardial infarction. A brief review. , 2002, American journal of clinical pathology.

[14]  H. Wolfe,et al.  Kinetic profiles by topographic compartments in muscle-invasive transitional cell carcinomas of the bladder: role of TP53 and NF1 genes. , 2002, American journal of clinical pathology.

[15]  T. Nakajima,et al.  Linkage disequilibrium and haplotype analysis among eight novel single-nucleotide polymorphisms in the human tissue-type plasminogen activator (t-PA) gene , 2001, Journal of Human Genetics.

[16]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[17]  T. Spector,et al.  The genetics of haemostasis: a twin study , 2001, The Lancet.

[18]  C. Glueck,et al.  The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. , 2000, Metabolism: clinical and experimental.

[19]  N. Wenger,et al.  The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. , 2000, Thrombosis research.

[20]  J. Carlquist,et al.  Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction. , 1999, Journal of the American College of Cardiology.

[21]  E Falk,et al.  Stable versus unstable atherosclerosis: clinical aspects. , 1999, American heart journal.

[22]  P. Reitsma,et al.  The 4G/5G Polymorphism in the Plasminogen Activator Inhibitor-1 Gene Is not Associated with Myocardial Infarction , 1999, Thrombosis and Haemostasis.

[23]  N. Samani,et al.  Distribution of Tissue Plasminogen Activator Insertion/Deletion Polymorphism in Myocardial Infarction and Control Subjects , 1998, Thrombosis and Haemostasis.

[24]  M. Margaglione,et al.  The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[25]  P. Ridker,et al.  Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[26]  A. Hofman,et al.  Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. , 1997, Circulation.

[27]  A. Hamsten,et al.  Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S E Humphries,et al.  Genetic determinants of arterial thrombosis. , 1994, Bailliere's best practice & research. Clinical haematology.

[29]  R. Rauramaa,et al.  HDL, HDL2, and HDL3 Subfractions, and the Risk of Acute Myocardial Infarction: A Prospective Population Study in Eastern Finnish Men , 1991, Circulation.

[30]  K. Stowman.  World health statistics. , 1949, The Milbank Memorial Fund quarterly.

[31]  M. Bai,et al.  Association of LT-α Ala252Gly gene polymorphism and the genetic predisposition of coronary heart disease in Chinese , 2009, Molecular Biology Reports.

[32]  M. Ishaq,et al.  PROFILE OF ACUTE MYOCARDIAL INFARCTION (AMI) IN PAKISTAN , 2007 .

[33]  R. Bernat,et al.  Impact of FXIII-A Val34Leu polymorphism on coronary artery disease in Croatian patients , 2007, Molecular Biology Reports.

[34]  R. Rauramaa,et al.  HDL, HDL_2, and HDL_3 subfractions, and the risk of acute myocardial infarction , 1991 .